To express interest, please contact WHO by 30 October 2026 at HTHPDT@who.int with the subject line “TB individual patient data set”. For more details please check: createsend.com/t/d-B2E7D997... #Tuberculosis #TBMeningitis #DataSharing

📢 WHO has launched a public call for individual participant data on the treatment of tuberculosis meningitis. Researchers and programmes with relevant datasets are encouraged to contribute and help strengthen the evidence base for TB meningitis treatment. #Tuberculosis #TBMeningitis #DataSharing

📢 The third and final WHO TB-IPD Data Access Committee meeting of 2026 will take place on 16 October. Researchers are welcome to submit data access requests by 2 October 2026. Queries & submissions: igh.tb-ipd@ucl.ac.uk #Tuberculosis #TBResearch #GlobalHealth

📢 SHINE trial data are now available through the WHO–UCL TB-IPD Platform! The platform now hosts data from 9 TB clinical trials. Submit Data Access Requests by 16 July 2026 for the 30 July DAC meeting. 📩 igh.tb-ipd@ucl.ac.uk #TBResearch #OpenScience

Planning a TB study? Consider including a data sharing plan with the WHO TB-IPD Platform to maximise the value of your research and support future evidence generation. 📩 igh.tb-ipd@ucl.ac.uk #TBResearch #OpenScience #EDCTP

Congratulations to all investigators whose proposals have progressed to Stage 2 of the EDCTP funding call! 🎉 We wish you every success as you develop your proposals and look forward to the exciting research ahead.

Interested in using TB-IPD data? 📅 The next TB-IPD Data Access Committee meeting will take place on 30 July 2026. Researchers wishing to request access to TB-IPD data should submit their application to igh.tb-ipd@ucl.ac.uk. by 16 July 2026. #Tuberculosis #OpenScience #Research

Also available: 📌 RIFAQUIN 📌 BEAT-TB 📌 SHINE (to be added) TB-IPD provides all available study data, including outcomes. More trial datasets are being added. Learn more: ucl.ac.uk/population-health-sciences/trials-data-summary 🧵2/2 #TBResearch #Tuberculosis #ClinicalTrials

Trials Data Summary

Trials Data Summaries for the TB-IPD. We provided all data available from each study, including the outcome data.

ucl.ac.uk

TB-IPD includes clinical trial data to support secondary analyses in TB research. Current studies include: 📌 STREAM 1&2 📌 TB-PRACTECAL 📌 MDR-END 📌 RIFASHORT 📌 RIFATOX 🧵1/2

What's in the platform? 📊 67,599 participants from observational studies 📊 3,900 participants from clinical trials 📊 1,000+ participants from the 2025 WHO public call From guideline development to new discoveries, these data continue generating value. Interested in using TB-IPD for your research?

What research questions could 70,000+ participant records help answer? TB-IPD now contains data from more than 70,000 participants across 112 datasets. #TB #OpenScience

TB-IPD Logo Challenge: 🗓 Deadline: 31 January 2026 📧 Submit to: igh.tb-ipd@ucl.ac.uk 🎁 Prize: £50 Love2shop voucher Get creative and take part!

🎨 TB-IPD Logo Challenge is open! Help shape the visual identity of the TB-IPD platform. We’re looking for original logo designs that reflect data sharing and open science.

🎨 To celebrate our social media launch, we’re opening a TB IPD logo challenge! Have an idea for a logo that represents collaboration, data, and TB research? Share your design — it might become the official TB IPD logo! 📅 Details and deadlines coming soon.

We’re inviting researchers, TB programmes, public health partners, and others interested in TB to: • Contribute de-identified TB data • Submit data access requests for research analysis Check our website to learn how to get involved and see the available datasets! Enquiries: igh.tb-ipd@ucl.ac.uk

🚀 The TB Individual Patient Data (IPD) Platform is now on Bluesky! Hosted at UCL and overseen by the UCL Centre for Global Tuberculosis Research, we bring together individual patient data to strengthen TB research, policy, and public health. 🔗 www.ucl.ac.uk/population-h...

TB-IPD platform

The TB treatment individual patient data platform (TB-IPD) is a collaborative initiative to support the generation of reliable evidence on the treatment of TB to inform future TB treatment guidelines.

ucl.ac.uk